Plunkett Research Online: Nascent Biotech Inc

NASCENT BIOTECH INC (NBIO:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nascent Biotech Inc is a United States based biopharmaceutical company. It is focused on the development and delivery of human antibodies and cytokine responses for the treatment of cancer. The company's products include Pritumumab, CLNH5 and MultiPharm. Pritumumab is a fully natural human IgG antib.....



Nascent Biotech Inc
Ticker: NBIO
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 601 21st Street
Suite 300
Vero Beach, FL 32960 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription

Nascent Biotech Inc is a United States based biopharmaceutical company. It is focused on the development and delivery of human antibodies and cytokine responses for the treatment of cancer. The company's products include Pritumumab, CLNH5 and MultiPharm. Pritumumab is a fully natural human IgG antib.....See More See More

Auditor: MaloneBailey, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: